Compounds > furosemide

furosemide and sulfathiazole

furosemide has been researched along with sulfathiazole in 7 studies

Research

Studies (7)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (14.29)	18.2507
2000's	4 (57.14)	29.6817
2010's	2 (28.57)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Strassburg, CP; Tukey, RH	1
Chang, TK; Ensom, MH; Kiang, TK	1
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M	1
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Albero, MI; García, MS; Ródenas, V; Sánchez-Pedreño, C	1
Bhattachar, SN; Fioritto, AF; Wesley, JA	1

Reviews

3 review(s) available for furosemide and sulfathiazole

Article	Year
Human UDP-glucuronosyltransferases: metabolism, expression, and disease. Annual review of pharmacology and toxicology, 2000, Volume: 40 Topics: Autoimmunity; Chromosome Mapping; Glucuronides; Glucuronosyltransferase; Humans; Hyperbilirubinemia; Neoplasms; Steroids; Terminology as Topic	2000
UDP-glucuronosyltransferases and clinical drug-drug interactions. Pharmacology & therapeutics, 2005, Volume: 106, Issue:1 Topics: Clinical Trials as Topic; Drug Interactions; Enzyme Activation; Enzyme Induction; Glucuronides; Glucuronosyltransferase; Humans; Pharmaceutical Preparations; Pharmacogenetics; Polymorphism, Genetic	2005
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016

Other Studies

4 other study(ies) available for furosemide and sulfathiazole

Article	Year
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors. Journal of medicinal chemistry, 2008, Nov-13, Volume: 51, Issue:21 Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship	2008
FDA-approved drug labeling for the study of drug-induced liver injury. Drug discovery today, 2011, Volume: 16, Issue:15-16 Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration	2011
Flow-injection spectrophotometric determination of frusemide or sulphathiazole in pharmaceuticals. Journal of pharmaceutical and biomedical analysis, 1997, Volume: 15, Issue:4 Topics: Diuretics; Dosage Forms; Flow Injection Analysis; Furosemide; Spectrophotometry; Sulfathiazole; Sulfathiazoles	1997
Solubility measurement of polymorphic compounds via the pH-metric titration technique. International journal of pharmaceutics, 2007, Feb-07, Volume: 330, Issue:1-2 Topics: Acetaminophen; Acetazolamide; Chlorpropamide; Crystallography, X-Ray; Fluoroquinolones; Furosemide; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Potentiometry; Pyrroles; Quinolones; Solubility; Sulfamethoxazole; Sulfathiazole; Sulfathiazoles; Thermodynamics; Titrimetry	2007